BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1000 related articles for article (PubMed ID: 18158083)

  • 21. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study.
    Kofteridis DP; Alexopoulou C; Valachis A; Maraki S; Dimopoulou D; Georgopoulos D; Samonis G
    Clin Infect Dis; 2010 Dec; 51(11):1238-44. PubMed ID: 20973727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
    Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
    J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study.
    Magret M; Amaya-Villar R; Garnacho J; Lisboa T; Díaz E; Dewaele J; Deja M; Manno E; Rello J;
    J Trauma; 2010 Oct; 69(4):849-54. PubMed ID: 20938271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
    Eagye KJ; Nicolau DP; Kuti JL
    Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinical study of subglottic secretion drainage for prevention of ventilation associated pneumonia].
    Zheng RQ; Lin H; Shao J; Chen QH; Lu NF; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jun; 20(6):338-40. PubMed ID: 18549711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
    J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventilator-associated pneumonia in surgical emergency intensive care unit.
    Ertugrul BM; Yildirim A; Ay P; Oncu S; Cagatay A; Cakar N; Ertekin C; Ozsut H; Eraksoy H; Calangu S
    Saudi Med J; 2006 Jan; 27(1):52-7. PubMed ID: 16432594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
    Cano EL; Haque NZ; Welch VL; Cely CM; Peyrani P; Scerpella EG; Ford KD; Zervos MJ; Ramirez JA; Kett DH;
    Clin Ther; 2012 Jan; 34(1):149-57. PubMed ID: 22284995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
    Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
    Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
    Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ventilator-associated pneumonia: Incidence, risk factors, outcome, and microbiology.
    Pawar M; Mehta Y; Khurana P; Chaudhary A; Kulkarni V; Trehan N
    J Cardiothorac Vasc Anesth; 2003 Feb; 17(1):22-8. PubMed ID: 12635056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.
    Gacouin A; Barbarot N; Camus C; Salomon S; Isslame S; Marque S; Lavoué S; Donnio PY; Thomas R; Le Tulzo Y
    Anesth Analg; 2009 Nov; 109(5):1584-90. PubMed ID: 19713267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The changing patterns and the associated factors of microbial pathogens in ventilator-associated pneumonia in a respiratory intensive care unit from 1995 to 2004].
    Yang W; He B; Zhao MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Aug; 31(8):598-602. PubMed ID: 19080406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.